Decoy Therapeutics is trading 6.23% up at $2.90, primarily amid broader pre-market strength.

  • It closed at $2.73 on September 10, 2026.
  • The company presented at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference on September 10; its CEO delivered a corporate overview and met investors.
  • Available coverage does not confirm the conference as the direct catalyst; major indices were up more than 0.5% in pre-market trading.